• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACSCANTO¿ II; COUNTER, DIFFERENTIAL CELL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACSCANTO¿ II; COUNTER, DIFFERENTIAL CELL Back to Search Results
Model Number 338962
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/24/2023
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that while using bd facscanto¿ ii a leakage of biohazard not contained within the instrument was observed.The following information was provided by the initial reporter: 1.Was the leak liquid or air? liquid.2.Was the leak contained within the instrument? not contained.3.(if not contained) was there spray of fluid under pressure? no.4.What was the fluid that leaked? biohazard.5.What is the source of leak ¿ before waste line or after waste line? after waste line -5b (if waste line) ¿ was waste mixed with bleach or decontaminate? no.6.Was the customer/bd personnel physically in contact with the fluid? no.
 
Manufacturer Narrative
Bdb has monitored its mdr reporting, and after review, has determined through valid data that: (1) the relevant malfunctions have not caused or contributed to further deaths or serious injuries for two years, and (2) the likelihood of another death or serious injury as a result of the relevant malfunctions is remote.Accordingly, bdb has amended its mdr reporting guidelines to discontinue further presumptive reporting of malfunctions associated with liquid leakage and splash complaints.Mfr.# 2916837-2023-00058 was filed under previous guidance and is now corrected to be a non-reportable event.Ii.The aforementioned amendment to the bdb mdr reporting guidelines was based on the following rationale: to evaluate the impact of this proposed change, an assessment of the complaint and adverse event reporting history was performed for malfunctions associated with serious injuries or deaths related to liquid leakage and splash events.The assessment confirms there have been no reports of serious injury or death related to liquid leakage or splash events for the last two years (()(6) 2020 thru (b)(6) 2022).Iii.We also note that the likelihood of another death or serious injury as a result of the relevant malfunctions is remote.Specifically, a liquid leakage or splash of a chemical or potentially biohazardous fluid would be readily apparent to the user and is unlikely to come in contact with eyes, mouth, other mucous membrane, and non-intact skin, or cause parenteral contact with blood or other potentially infectious materials.Users are also instructed to follow universal precautions including wearing ppe per the products user documentation, and the requirements in the osha bloodborne pathogen guideline.As such, the risk of serious injury or death occurring related to malfunctions causing liquid leakage or splash events would be improbable.
 
Event Description
It was reported that while using bd facscanto¿ ii a leakage of biohazard not contained within the instrument was observed.The following information was provided by the initial reporter: 1.Was the leak liquid or air? liquid.2.Was the leak contained within the instrument? not contained.3.(if not contained) was there spray of fluid under pressure? no.4.What was the fluid that leaked? biohazard.5.What is the source of leak ¿ before waste line or after waste line? after waste line -5b (if waste line) ¿ was waste mixed with bleach or decontaminate? no.6.Was the customer/bd personnel physically in contact with the fluid? no.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACSCANTO¿ II
Type of Device
COUNTER, DIFFERENTIAL CELL
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key16475508
MDR Text Key310879691
Report Number2916837-2023-00058
Device Sequence Number1
Product Code OYE
UDI-Device Identifier00382903389629
UDI-Public00382903389629
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K141468
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number338962
Device Catalogue Number338962
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/26/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-